News

Three biomedical research projects conducted NCSU Wilson College of Textiles researchers demonstrate advances in health care ...
Enantiomers, or molecule pairs that are mirror images of each other, make up more than half of FDA-approved drugs in use ...
The researchers packed the encapsulin with doxorubicin (a chemotherapy drug used to treat various cancers), which triggered the structure’s assembly in vitro (outside a living organism). Since ...
This review extensively assesses the structure, categories ... Additionally, LBNPs enhance the sensitivity of cancer cells to chemotherapy, radiotherapy, and immunotherapy, by overcoming drug ...
A new study published in Nature reveals an unexpected structure ... radiation and chemotherapy. This selective action mirrors the approach used by PARP inhibitors, the first drugs approved to ...
Thymine and uracil make up part of the structure of our genes ... They might have: Without enough DPD enzyme, these chemotherapy drugs build up in the body and cause more severe side effects than ...
Chemotherapy lacks such a specificity ... The difference is lazertinib’s structure, rigidified into the active binding mode by unique interactions within the drug molecule. So, if you were designing a ...
Chemotherapy lacks such a specificity ... The difference is lazertinib’s structure, rigidified into the active binding mode by unique interactions within the drug molecule. So, if you were designing a ...
Vertex Pharmaceuticals will use Orum Therapeutics’ dual-precision targeted protein degradation (TPD² ®) technology platform to discover targeted conditioning agents for use with gene editing ...
Clinical trials have now been initiated to test if the epilepsy drug, called stiripentol, makes chemotherapy work ... is responsible for altering the structure of a key protein involved in DNA ...
Chemotherapy, the treatment of choice for invasive cancers ... This strategy consists of the use of a drug structure-directing agent (DSDA) that plays a dual role, acting as a pharmacological prodrug ...